Chesnara buys £1.7bn assets MetLife UK closed-book business

Chesnara acquired MetLife UK's closed-book business, including 18,000 policies and £1.7bn in assets. The deal is expected to boost Chesnara's own funds and contractual service margin by £45m, with £90m in lifetime cashflows, half within five years. MetLife UK closed to new business in 2017.

Original reporting
Published Nov 6, 2026, 9:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 3:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Chesnara buys £1.7bn assets MetLife UK closed-book business — source image
Decision brief

The 30-second read

$METBullishMed
01

Why it matters

The transaction is expected to be accretive to MetLife's own funds and contractual service margin by about £45m, with lifetime cashflows of ~£90m.

02

Market read

First disclosure of a multi‑billion‑pound insurance asset sale, likely to move MetLife stock and signal consolidation trends in the sector.

03

What to watch

Regulatory approval risk and integration costs for Chesnara may temper the perceived benefits.

Relevance 8/10Novelty 8/10Timing: immediate, impact expected in pre‑market trading today

Background

Chesnara, a UK‑based insurer, is acquiring MetLife UK's closed‑book portfolio, excluding the protection business, for £1.7bn.

Company-level read

Ticker impact

$METBullishHigh confidence
Context

MetLife agreed to sell its UK closed‑book business assets (~£1.7bn) to Chesnara, a new M&A transaction disclosed in this article.

Expected impact

potential modest upside as the market prices in the cash inflow from the asset sale

Evidence & confidence

First‑report of a sizable (£1.7bn) asset divestiture; investors typically view cash‑generating sales favorably.

Market effects

Highlights continued consolidation in the UK life‑insurance market and may prompt peers to consider similar asset sales.

UK insurance sector could see modest re‑rating as the transaction signals valuation of closed‑book books.

MetLife is a large US insurer; the deal adds to global M&A flow and may affect investor sentiment toward insurance stocks.

Counterpoint

The sale could be seen as a retreat from the UK market, potentially raising concerns about growth prospects.

Key entities

  • Chesnara

    UK insurer acquiring MetLife UK's closed‑book assets.

  • MetLife

    US‑listed insurer selling its UK closed‑book business.

Related articles

$METHighAI 8/10

MetLife Q3 Earnings Call Highlights

MetLife reported Q3 earnings, with variable investment income of $1.5B for the first nine months, on track to exceed its $1.6B full-year guidance. Group Benefits and Retirement adjusted earnings rose 14% and 12% respectively. International operations saw mixed results, with Asia up 21% and Latin America down 5%. The company repurchased $650M in shares in Q3 and is on track to meet its full-year targets.

$METMedAI 8/10

Chesnara bags £1.7bn MetLife UK closed life book in latest takeover

Chesnara agreed to acquire MetLife UK's closed-book life insurance business for £1.7bn in assets, subject to regulatory approval. The deal is expected to generate £90m in lifetime cashflows, with £45m added to Own Funds and Contractual Service Margin. Chesnara aims to strengthen its UK business and future cash generation. Analysts note the deal boosts long-term capital generation without significantly impacting Chesnara's acquisition firepower.

$METMed

Chesnara To Buy MetLife's Closed-book UK Life Insurance Firm; Terms Not Disclosed

Chesnara plc (CSN.L) agreed to buy MetLife's (MET) closed-book UK life insurance unit, MetLife UK Limited, for an undisclosed sum. The deal, expected to close in early 2027, will add 18,000 policies and £1.7 billion in assets. Chesnara anticipates £45 million boost to Own Funds and Contractual Service Margin, with £90 million in lifetime cash flows, half within five years. Shares rose 1.15%.

$METHighAI 9/10

MetLife (MET) Q3 2026 Earnings Call Transcript

MetLife (MET) reported Q3 2026 adjusted earnings of $1.8B ($2.85 EPS), up 17% YoY. Adjusted EPS ex-items rose 22%, with ROE at 19.6%. Growth was driven by Group Benefits, Retirement & Income Solutions, and Asia. The company repurchased $650M in shares, bringing YTD capital return to $3.5B.